Pericardial disease in patients treated with immune checkpoint inhibitors

BACKGROUND: There are limited data on the occurrence, associations and outcomes of pericardial effusions and pericarditis on or after treatment with immune checkpoint inhibitors (ICIs). METHODS: This was a retrospective study at a single academic center that compared 2842 consecutive patients who re...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Immunother Cancer
Asıl Yazarlar: Gong, Jingyi, Drobni, Zsofia Dora, Zafar, Amna, Quinaglia, Thiago, Hartmann, Sarah, Gilman, Hannah K, Raghu, Vineet K, Gongora, Carlos, Sise, Meghan E, Alvi, Raza M, Zubiri, Leyre, Nohria, Anju, Sullivan, Ryan, Reynolds, Kerry L, Zlotoff, Daniel, Neilan, Tomas G
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BMJ Publishing Group 2021
Konular:
Clinical/Translational Cancer Immunotherapy
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8215235/
https://ncbi.nlm.nih.gov/pubmed/34145031
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2021-002771
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller